Aura Biosciences, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveOct 1 →InsidersNo open-market buys. 8 insiders sold $40.1M, 0 of 14 sales on a 10b5-1 plan.→HoldersTCG Crossover 9.2%Montanova Capital 7.0%Frazier Life Sciences 6.9%→Financing →PeersClosest companies: CGEM, VRDN, TNGX→
From the filings
Figures
- Net income
- −$131.0Mlast 12 months
- Operating cash flow
- −$91.3Mlast 12 months
- Cash and equivalents
- $67.8Mat the last balance sheet
- Shares outstanding
- 103.5M shareson issue